HWA
WST icon

HHM Wealth Advisors’s West Pharmaceutical WST Stock Holding History

HHM Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$22.4K – 946
2025
Q1 		$22.4K Sell
100
-3
-3% -$827 ﹤0.01% 484
2024
Q4 		$33.7K Buy
103
+3
+3% +$944 ﹤0.01% 420
2024
Q3 		$30K Hold
100
– – ﹤0.01% 413
2024
Q2 		$32.9K Hold
100
– – 0.01% 391
2024
Q1 		$39.6K Buy
+100
New +$37K 0.01% 328

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

HHM Wealth Advisors's WST Position: Q2 2025 in Review

HHM Wealth Advisors sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 100 shares — an estimated $22.4K sold.

HHM Wealth Advisors first reported a position in WST in Q1 2024 and held it in 5 quarters. The position peaked at $39.6K in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • HHM Wealth Advisors reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • HHM Wealth Advisors sold 100 West Pharmaceutical shares in Q2 2025, an estimated $22.4K.
  • HHM Wealth Advisors first reported a position in West Pharmaceutical in Q1 2024 and held it in 5 quarters.
  • HHM Wealth Advisors's West Pharmaceutical position peaked at $39.6K in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on HHM Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.